₹18.31
−0.70%NSE close, 16 Nov 2026
−63.26%
Medico Remedies is a small cap company, listed on NSE under the symbol MEDICO. At ₹18.31 a share, the market values the whole company at ₹152 crore.
In FY26, it reported sales of ₹206 crore and a net profit of ₹13 crore, an operating margin of 8.3%. Over the last three years, sales grew 13.7% a year and net profit grew 21.9% a year.
The market values the company at 11.1 times its profit over the last twelve months and 1.89 times its book value; its return on equity is 17.0% and its borrowings are 0.40 times its equity.
Promoters hold 61.38% of the shares. Foreign institutions hold 0.60%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 63.3%, and it is 67.8% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
The financial results for the period ended September 30, 2026.
Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to…
Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to…
A copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange regarding voting results.
| Dec 2025 |
|---|
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 29.8 | 41.3 | 30.8 | 39.4 | 39.5 | 41.3 | 38.3 | 52.6 | 58.7 | 56.8 | 69.4 | 74.0 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 27.0 | 36.7 | 28.0 | 36.9 | 36.4 | 34.6 | 35.4 | 49.9 | 54.4 | 49.7 | 66.1 | 70.8 |
| Operating profit | 2.7 | 4.7 | 2.8 | 2.4 | 3.1 | 6.7 | 2.8 | 2.7 | 4.3 | 7.2 | 3.3 | 3.2 |
| Operating margin | 9.2% | 11.3% | 9.1% | 6.1% | 7.9% | 16.2% | 7.4% | 5.2% | 7.4% | 12.6% | 4.8% | 4.3% |
| Other income | 0.3 | 0.6 | 0.3 | 0.7 | 1.4 | 0.3 | 0.7 | 1.7 | 0.7 | 2.9 | 1.2 | 1.3 |
| Interest | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 | 0.5 | 0.3 | 0.2 | 0.4 | 0.9 | 0.4 | 0.5 |
| Depreciation | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 |
| Profit before tax | 2.1 | 4.3 | 2.2 | 2.1 | 3.5 | 5.7 | 2.4 | 3.5 | 3.8 | 8.3 | 3.3 | 3.3 |
| Tax | 0.6 | 1.2 | 0.6 | 0.6 | 0.9 | 1.4 | 0.6 | 0.9 | 1.0 | 2.5 | 0.8 | 0.9 |
| Net profit | 1.5 | 3.1 | 1.6 | 1.6 | 2.6 | 4.3 | 1.8 | 2.6 | 2.9 | 5.9 | 2.5 | 2.4 |
| EPS (₹) | 0.17 | 0.37 | 0.19 | 0.19 | 0.32 | 0.52 | 0.22 | 0.31 | 0.35 | 0.71 | 0.30 | 0.29 |
₹ crore, financial years to March.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 140 | 145 | 151 | 206 |
| Expenses | 131 | 132 | 136 | 189 |
| Operating profit | 9.5 | 12.9 | 15.0 | 17.0 |
| Operating margin | 6.8% | 8.9% | 9.9% | 8.3% |
| Other income | 4.1 | 2.1 | 2.7 | 5.9 |
| Interest | 0.8 | 0.8 | 1.2 | 1.8 |
| Depreciation | 2.7 | 2.9 | 3.0 | 3.1 |
| Profit before tax | 10.1 | 11.3 | 13.5 | 18.1 |
| Tax | 2.9 | 3.1 | 3.4 | 4.9 |
| Net profit | 7.3 | 8.3 | 10.1 | 13.1 |
| EPS (₹) | 3.52 | 0.99 | 1.22 | 1.58 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 4.9 | 5.9 | 4.3 |
| From investing | −3.5 | −4.5 | −2.4 |
| From financing | −0.5 | −0.6 | −0.3 |
| Spent on fixed assets | 0 | 0 | −2.3 |
| Free cash flow | 4.9 | 5.9 | 2.0 |
Margins, returns, debt, tax and cash.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 5.2% | 5.7% | 6.7% | 6.4% |
| Operating margin | 6.8% | 8.9% | 9.9% | 8.3% |
| Return on equity | 16.5% | 15.8% | 16.2% | 17.4% |
| Return on capital employed | 20.2% | 20.1% | 19.0% | 21.1% |
| Return on assets | 8.3% | 8.6% | 8.4% | 8.6% |
| Debt to equity | 0.22 | 0.15 | 0.24 | 0.25 |
| Interest coverage | 14.50 | 14.80 | 12.60 | 11.00 |
| Debt to assets | 0.11 | 0.08 | 0.12 | 0.12 |
| Current ratio | 1.55 | 1.72 | 1.70 | 1.66 |
| Quick ratio | 1.08 | 1.34 | 1.23 | 1.27 |
| Cash ratio | 0.02 | 0.00 | 0.02 | 0.02 |
| Asset turnover | 1.61 | 1.51 | 1.26 | 1.35 |
| Fixed asset turnover | 6.91 | 7.15 | 7.35 | 10.27 |
| Inventory turnover | – | 6.70 | 4.10 | 5.00 |
| Receivables turnover | 3.90 | 2.90 | 2.60 | 2.50 |
| Gross margin | – | 24.2% | 28.2% | 26.7% |
| Cash from operations to profit | – | – | 48.0% | 45.0% |
| Effective tax rate | 28.3% | 26.9% | 25.3% | 27.4% |
Proceedings of Annual General Meeting held on September 22, 2026
Book Closure Dates.
Notice of undefined to be held on September 22, 2026
The financial results for the period ended Jun 30, 2026.
Significant movement in price has been observed in Medico Remedies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to…
A copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011